Portfolio Lab

Gilead Sciences, Inc.

  • Stock
  • Ticker GILD
  • ISIN US3755581036
  • Nasdaq

Health care · Biotechnology · USA

$166.43 −0.06%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Gilead Sciences, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

GILDGlobal equities (VT)

$10,000 grew to $31,626. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −30.5% in 12/2020, measured from the peak in 04/2020. It took 30 months to get back to the old peak.

1-year return
+36.4%
5-year return p.a.
+23.7%
10-year return p.a.
+12.2%
Volatility p.a.
23.8%
Largest decline
−30.5%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue7,5696,6677,0827,7697,9256,9607,8038,300
Gross profit5,9885,1275,5816,2006,3015,5156,2246,729
Operating income2,4522,2372,4743,3271,9842,586-10,3943,462
EBITDA2,5472,3342,5673,4172,0742,679-10,2963,594
Net income1,7831,3151,9603,0522,1832,021-10,4962,429
Earnings per share1.421.041.562.431.741.61-8.451.94
Balance sheet
Total assets58,99556,43455,72158,53359,02356,27849,36251,408
Liabilities39,74937,35636,13137,07736,40532,84737,61838,453
Equity19,33019,16219,67421,54022,70323,51511,82913,040
Cash9,9917,9265,1447,3307,5647,6283,1796,437
Long-term debt24,89622,14622,14022,13522,12920,86123,83223,815
Cash flow
Operating cash flow2,9751,7578274,1083,3272,5443,5735,035
Capital expenditure-147-104-107-147-205-117-140-237
Free cash flow2,8281,6537203,9613,1222,4273,4334,798

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +36.6%, weakest 2018 at −9.9%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
30 Oct 2026$1.94
6 Aug 2026−$8.45
7 May 2026$1.61
24 Feb 2026$1.74
7 Nov 2025$2.43
7 Aug 2025$1.56
7 May 2025$1.04
28 Feb 2025$1.42
12 Nov 2024$1.00
8 Aug 2024$1.29
8 May 2024−$3.34
23 Feb 2024$1.13

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€187bn
Market cap in trading currency
$206bn
Enterprise value
$226bn
P/E
–
P/S
6.66
P/B
15.83
EV/Sales
7.30
EV/EBITDA
–
Earnings yield
–
FCF yield
6.7%

Results (last four quarters)

Revenue
$31.0bn
Gross profit
$24.8bn
EBITDA
−$1.95bn
Net income
−$3.86bn
Earnings per share
−$3.16
Revenue per share
$24.98
Revenue growth
+6.8%
Earnings growth
−20.4%

Profitability

Gross margin
79.9%
Operating margin
-7.6%
Net margin
-12.5%
Return on equity
-22.3%
Return on assets
-7.5%

Balance sheet and cash flow

Cash
$6.44bn
Cash per share
$5.19
Financial debt
$26.2bn
Debt/equity %
201
Current ratio
1.38
Book value per share
$10.51
Operating cash flow
$14.5bn
Free cash flow
$13.8bn

Dividend

Dividend yield
1.95%
Dividend (12 months)
$3.25
Yield (12 months)
1.95%
Payout ratio
–
Ex-dividend date
15 Sep 2026

Shares and trading

Shares outstanding
1.24bn
Volume
7.44m
Avg. volume 3 months
6.02m
Relative volume
1.3

Price and technicals

Price
$166.43
1 day
−0.1%
52-week high
$174.48
52-week low
$118.30
Distance to 52-week high
−4.6%
Distance to 52-week low
+40.7%
Distance to 50-day line
+5.8%
Distance to 200-day line
+17.0%
RSI (14)
54
Volatility 1M
30.2%

Performance

1 week
−1.0%
1 month
+5.9%
3 months
+13.4%
6 months
+23.9%
YTD
+35.6%
1 year
+30.0%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has GILD performed since 11/2016?

$10,000 grew to $31,626 by 20 Nov 2026, which is +12.2% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is GILD?

Volatility was 23.8% per year, measured on monthly returns. The largest decline from a peak was −30.5%, with the low in 12/2020.

How does GILD compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, GILD returned +12.2% at 23.8%. The correlation of monthly returns was 0.22; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Gilead Sciences, Inc. (GILD): Return and risk